
POAI P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.52
Average-0.5245
Median-0.5250
Minimum-0.5900
Maximum-0.4700
-0.52
Past Month+0.07 (11.86%)
The P/E ratio for POAI is -0.52 as of Jun 13, 2025. This represents a increase of 44.44% compared to its 12-month average P/E ratio of -0.36. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Predictive Oncology Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Predictive Oncology Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Predictive Oncology Inc to industry peers.
Predictive Oncology Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Predictive Oncology Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Predictive Oncology Inc to industry peers.
POAI P/E Ratio Insights
See Predictive Oncology Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in POAI
Order type
Buy in
Order amount
Est. shares
0 shares
POAI P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $0.95 | -0.51 |
May 1, 2025 | $1.17 | -0.46 |
Apr 1, 2025 | $1.48 | -0.59 |
Mar 3, 2025 | $1.26 | -0.41 |
Feb 3, 2025 | $1.39 | -0.45 |
Jan 2, 2025 | $0.92 | -0.30 |
POAI End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.52 | +92.59% |
2024 | -0.27 | -61.97% |
2023 | -0.71 | -13.41% |
2022 | -0.82 | -69.17% |
2021 | -2.66 | +885.19% |
2020 | -0.27 | — |
FAQs About Predictive Oncology Inc (POAI) P/E ratio
The latest P/E ratio of POAI is -0.52, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Predictive Oncology Inc’s last 12-month average P/E ratio is -0.36, compared to its current P/E ratio of -0.52. This reflects a increase of 44.44%.
Predictive Oncology Inc’s current P/E ratio of -0.52 is higher than its last 12-month average P/E of -0.36. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Predictive Oncology Inc’s average P/E ratio over the last 3 years is -0.7. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Predictive Oncology Inc’s average P/E ratio over the last 5 years is -0.82. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.